bis-(2-chloro-ethyl)-[4-(4-nitro-phenyl)-2-oxo-2lambda*5*-[1,3,2]oxazaphosphinan-2-yl]-amine

ID: ALA213994

Chembl Id: CHEMBL213994

PubChem CID: 11417676

Max Phase: Preclinical

Molecular Formula: C13H18Cl2N3O4P

Molecular Weight: 382.18

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=[N+]([O-])c1ccc(C2CCOP(=O)(N(CCCl)CCCl)N2)cc1

Standard InChI:  InChI=1S/C13H18Cl2N3O4P/c14-6-8-17(9-7-15)23(21)16-13(5-10-22-23)11-1-3-12(4-2-11)18(19)20/h1-4,13H,5-10H2,(H,16,21)

Standard InChI Key:  BLLAFAYLTBTTPF-UHFFFAOYSA-N

Associated Targets(Human)

SK-OV-3 (52876 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CRYZ Tbio Quinone oxidoreductase (9 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

V79 (1637 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 382.18Molecular Weight (Monoisotopic): 381.0412AlogP: 3.53#Rotatable Bonds: 7
Polar Surface Area: 84.71Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 13.49CX Basic pKa: 0.03CX LogP: 1.82CX LogD: 1.82
Aromatic Rings: 1Heavy Atoms: 23QED Weighted: 0.34Np Likeness Score: -0.48

References

1. Jiang Y, Han J, Yu C, Vass SO, Searle PF, Browne P, Knox RJ, Hu L..  (2006)  Design, synthesis, and biological evaluation of cyclic and acyclic nitrobenzylphosphoramide mustards for E. coli nitroreductase activation.,  49  (14): [PMID:16821793] [10.1021/jm051246n]
2. Jiang Y, Han J, Yu C, Vass SO, Searle PF, Browne P, Knox RJ, Hu L..  (2006)  Design, synthesis, and biological evaluation of cyclic and acyclic nitrobenzylphosphoramide mustards for E. coli nitroreductase activation.,  49  (14): [PMID:16821793] [10.1021/jm051246n]
3. Nepali K, Lee HY, Liou JP..  (2019)  Nitro-Group-Containing Drugs.,  62  (6): [PMID:30295477] [10.1021/acs.jmedchem.8b00147]

Source